Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Catherine Humphreys"'
Autor:
Tom J. Moullaali, Rachel Walters, Mark Rodrigues, Neshika Samarasekera, Jose Bernal, Xia Wang, Catherine Humphreys, Joanna M. Wardlaw, Andrew Farrall, Colin Smith, Craig S. Anderson, Rustam Al-Shahi Salman, Brian McKinstry
Publikováno v:
Frontiers in Stroke, Vol 2 (2023)
IntroductionThe role of systolic blood pressure (SBP) variability in the pathogenesis of cerebral amyloid angiopathy (CAA) as an underlying cause of intracerebral hemorrhage (ICH) is unknown. We studied SBP variability before ICH according to CAA sev
Externí odkaz:
https://doaj.org/article/858093f7cde94ed489980126ef063f51
Autor:
B. T. Rhodes, Claudia Roxana Vintilescu, Lauren Nye, Ricardo Costa, Alfred Rademaker, Scott H. Okuno, Mohammed M. Milhem, B. C. Prunder, Steven I. Robinson, Rasima Cehic, Mark Agulnik, D. Daniels, Ariel Polish, Thomas McFarland, B.A. Van Tine, Keith M. Skubitz, Susan Abbinanti, Catherine Humphreys
Publikováno v:
Annals of Oncology. 28:121-127
Background Soft tissue sarcomas (STSs) overexpress vascular endothelial growth factors (VEGF) and VEGF-receptors (VEGFR) activation have been associated with tumor aggressiveness. Tivozanib is a potent small molecule tyrosine kinase inhibitor against
Autor:
Steven Attia, Catherine Humphreys, Alfred Rademaker, Steven I. Robinson, Mark Agulnik, Bethany C. Prudner, Rasima Cehic, Nisha Mohindra, Scott H. Okuno, Susan Abbinanti, Brian A. Van Tine, Mohammed M. Milhem
Publikováno v:
Journal of Clinical Oncology. 36:11550-11550
11550Background: Topotecan and pazopanib (PAZ) individually have clinical benefit in patients (pts) with sarcomas. PAZ is a multi-tyrosine kinase inhibitor and topotecan affects endothelial cells, ...
Autor:
Mark Agulnik, Mohammed M. Milhem, Alfred Rademaker, Catherine Humphreys, Susan E. Abbinanti, Lauren Elizabeth Nye, Rasima Cehic, Ariel Polish, Claudia Roxana Vintilescu, Thomas McFarland, Keith M. Skubitz, Steven Ian Robinson, Scott H. Okuno, Brian Andrew Van Tine
Publikováno v:
Journal of Clinical Oncology. 33:10515-10515
Autor:
Mark Agulnik, Brian A. Van Tine, Keith M. Skubitz, Rasima Cehic, Catherine Humphreys, Susan Abbinanti, Alfred Rademaker, Steven I. Robinson, Lauren Nye, Ariel Polish, Scott H. Okuno, Mohammed M. Milhem, Thomas McFarland, Claudia Roxana Vintilescu
Publikováno v:
Journal of Clinical Oncology. 32:TPS10604-TPS10604
10515 Background: Despite a multi-modality approach, many patients (pts) with early stage soft tissue sarcomas (STS) will develop recurrent or metastatic disease. Treatment options for these pts ar...